Episode Details
Back to Episodes316: The long journey to make malaria vaccines, and Sarepta's ties with patient advocates
Published 2 years, 2 months ago
Description
Andrew Joseph, STAT's Europe correspondent, joins us to talk about his special report on the 40-year quest to develop the world's first malaria vaccines. We also cover the latest news in the biotech industry, including Sarepta Therapeutics' move to censor a patient video, data from a new Duchenne gene therapy, and a campaign by Mount Sinai to stifle debate about its controversial brain research following revelations made by a STAT investigation.